A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs-Reference-Cited by-同舟云学术

A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs

Published:2024-03 Issue: Volume:223 Page:105819
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Shimura Mari,Higashi-Kuwata Nobuyo^ORCID,Fujiwara Asuka,Taniguchi Mai,Ichinose Takayuki,Hamano Fumie,Uematsu Masaaki,Inoue Takato,Matsuyama Satoshi^ORCID,Suzuki Takahiro^ORCID,Ghosh Arun K.,Shindou Hideo,Shimuzu Takao,Mitsuya Hiroaki^ORCID

Funder

Japan Science and Technology Agency

Government of Japan Ministry of Health Labour and Welfare

Takeda Science Foundation

Japan Agency for Medical Research and Development Department of Industrial Academic Collaboration

Japan Agency for Medical Research and Development

NCGM

Government of Japan Ministry of Education Culture Sports Science and Technology

Publisher

Elsevier BV

Reference69 articles.

1. Malnutrition and lipid abnormalities in antiretroviral naïve HIV-infected adults in Addis Ababa: a cross-sectional study;Adal;PLoS One,2018

2. Steroid - mediated liver steatosis is CD1d - dependent, while steroid - induced liver necrosis, inflammation and metabolic changes are CD1d - independent;Adar;BMC Gastroenterol.,2022

3. GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants;Aoki;Sci. Adv.,2023

4. A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistance;Aoki;Glob. Heal. Med.,2019

5. A novel central nervous system- penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency;Aoki;Elife,2017